Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031278 |
2-chloroethyl ethyl sulfide |
2-chloroethyl ethyl sulfide results in decreased expression of BIK mRNA | decreases expression | 12208782
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of BIK mRNA | decreases expression | 18648102
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of BIK protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of BIK mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of BIK mRNA | increases expression | 19730151
|
D001374 |
Azacitidine |
[Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 21224363
|
D001374 |
Azacitidine |
Azacitidine results in increased expression of BIK mRNA | increases expression | 21224363
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of BIK mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BIK mRNA | decreases expression | 19150397
|
D002251 |
Carbon Tetrachloride |
[Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 16610055
|
D002784 |
Cholesterol |
Cholesterol analog results in increased expression of BIK mRNA | increases expression | 19477266
|
D003024 |
Clozapine |
Clozapine results in increased expression of BIK mRNA | increases expression | 16160616
|
D003024 |
Clozapine |
CSF3 protein inhibits the reaction [Clozapine results in increased expression of BIK mRNA] | decreases reaction|increases expression | 16160616
|
D003042 |
Cocaine |
Cocaine affects the expression of BIK mRNA | affects expression | 15681117
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of BIK mRNA | decreases expression | 17403535
|
C014347 |
decitabine |
[decitabine co-treated with Depsipeptides] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 17064661
|
C014347 |
decitabine |
decitabine results in increased expression of BIK protein | increases expression | 17064661
|
C014347 |
decitabine |
Depsipeptides promotes the reaction [decitabine results in increased expression of BIK protein] | increases expression|increases reaction | 17064661
|
D047630 |
Depsipeptides |
[decitabine co-treated with Depsipeptides] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 17064661
|
D047630 |
Depsipeptides |
Depsipeptides promotes the reaction [decitabine results in increased expression of BIK protein] | increases expression|increases reaction | 17064661
|
D047630 |
Depsipeptides |
Depsipeptides results in increased expression of BIK mRNA | increases expression | 17064661
|
D047630 |
Depsipeptides |
Depsipeptides results in increased expression of BIK protein | increases expression | 17064661
|
D004317 |
Doxorubicin |
BIK protein results in increased susceptibility to Doxorubicin | increases response to substance | 16007125
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of BIK mRNA | decreases expression | 16705698
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of BIK mRNA | decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of BIK protein | increases expression | 17638070
|
D000431 |
Ethanol |
[Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 16610055
|
D005047 |
Etoposide |
BIK protein results in increased susceptibility to Etoposide | increases response to substance | 16007125
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of BIK mRNA | increases expression | 18035473
|
D005665 |
Furosemide |
Furosemide affects the expression of BIK mRNA | affects expression | 17497460
|
C118739 |
N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide |
[Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 21224363
|
C076029 |
olanzapine |
olanzapine results in increased expression of BIK mRNA | increases expression | 16160616
|
C019248 |
pamidronate |
BIK protein results in increased susceptibility to pamidronate | increases response to substance | 16007125
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of BIK mRNA | increases expression | 19482888
|
C031280 |
pyrazole |
[Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 16610055
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of BIK mRNA | decreases expression | 18175754
|
D013629 |
Tamoxifen |
ESR2 protein promotes the reaction [Tamoxifen results in increased expression of BIK protein] | increases expression|increases reaction | 17638070
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of BIK mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of BIK mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of BIK mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of BIK mRNA | affects expression | 14718646
|
D014520 |
Urethane |
Urethane results in increased expression of BIK mRNA | increases expression | 16978161
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.26 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
12.63 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
12.63 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.63 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.54 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.54 | 11192467 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
12.76 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.76 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
12.76 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
12.76 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
12.76 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.43 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.34 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.34 | 6695378 |
MESH:D000236 |
Adenoma |
|
Urethane |
10.34 | 10822126 16926031 6695378 10530776 17195641 11497255 17093202 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
9.15 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.15 | 16835633 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.78 | 14617031 12649775 16160616 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.28 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.03 | 15451039 15451040 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.71 | 11748828 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.55 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.79 | 11141031 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.80 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.33 | 15014928 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
4.08 | 16632123 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
3.39 | 17069543 18685284 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.73 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.13 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.13 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.59 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.21 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
11.21 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
pamidronate |
5.65 | 15845617 8053405 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.57 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.49 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
4.49 | 16978400 11325840 17020986 18323546 17388661 15136595 18234424 15093573 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
4.49 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.49 | 18628466 15136595 16096432 19526202 11325840 15567936 16115903 17426702 17369602 16595493 17983394 16264153 15692762 16935488 15668708 18695136 15993339 16322301 18234424 15939500 16826403 15634643 15994142 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.49 | 12948864 16675129 17018787 17261762 19861407 14630087 17289903 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
4.49 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.49 | 21138602 18997820 20859285 20065188 19011961 18351453 19200415 17440819 19410462 19142967 17261762 18855134 21152245 16873071 19084267 19066611 19288272 19244106 20390343 17242785 17893378 18425577 20135344 19487384 18815881 16273361 18629630 18984771 19221464 18821012 19155303 17049068 20544844 19059307 19115204 19289846 19189212 16202921 11161223 19103187 19189210 16818667 15565566 20005174 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.49 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.07 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
4.38 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.18 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.51 | 16192424 16097048 3786805 16124888 15721981 16050911 16227642 18705752 15700767 16011737 15673190 10355542 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.53 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.58 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.23 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
21.94 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
21.94 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
21.94 | 15553829 11135700 16217749 15073043 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
21.94 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
21.94 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
21.94 | 18059187 16234567 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
21.94 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
21.94 | 15289165 18788625 15763234 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
21.94 | 20935162 1701930 6705139 20007298 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
21.94 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.61 | 16152834 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.59 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
10.09 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
10.09 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.09 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.88 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.08 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.08 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.08 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.37 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.33 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.33 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.35 | 16364871 17308081 17329180 17924179 17131338 16455267 18627295 17382496 16651473 16242529 17351982 16612575 15792986 17007740 16731534 15476868 16278810 17519947 16952015 16109756 15505089 17928571 16269455 15811867 17974986 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.85 | 16243910 17334414 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.97 | 18071103 16772815 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.06 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.06 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.06 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.98 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.94 | 19486331 9022650 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.48 | 15894690 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.44 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
9.30 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.30 | 15340226 8697196 15668235 12621046 16354765 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
9.30 | 12810352 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.44 | 19606084 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.69 | 17123785 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.29 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
4.61 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
4.61 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.61 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.61 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.92 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.64 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
3.64 | 15451040 11198716 10194807 15451039 15513904 19302082 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 20055451 15322242 10048152 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.70 | 11948286 18093676 10498854 15643279 15276878 16413132 16614059 12388444 18372110 16989017 10700343 16651033 17010015 18295254 12913760 18710439 17979934 18433785 18483878 12161096 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.84 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.09 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.54 | 18759878 11906362 12868966 8970840 11298694 8156756 14531868 2524372 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.23 | 2952479 3621924 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.51 | 17069543 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.54 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.84 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.13 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.27 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.27 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.06 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.06 | 19279558 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.27 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
17.34 | 9022650 18648102 8291058 18692083 1440618 11289319 9328219 9653073 7440962 6482804 6679447 18289764 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
17.34 | 15027814 6623471 6884620 4309450 7179309 3786805 2869522 7120509 10092053 15968718 19336974 9327722 11566570 3732212 10915739 15998439 21278145 17522070 16227642 19085960 16177239 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
17.34 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
17.34 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
17.34 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
17.34 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.34 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.43 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.43 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.99 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.66 | 16935035 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.75 | 1851702 |
MESH:D004487 |
Edema |
|
Furosemide |
6.28 | 11834646 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.28 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.62 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.27 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.83 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
11.42 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.42 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.42 | 16202921 17893378 20544844 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.78 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.87 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.94 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.83 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.59 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.75 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.31 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.98 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.74 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
13.01 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
13.01 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
13.01 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
13.01 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
13.01 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
16.77 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
16.77 | 12795759 16239168 17595544 12631006 15959796 61145 16045604 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
16.77 | 16409862 18620774 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
16.77 | 19224547 14986274 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.38 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.07 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.02 | 16946407 10194807 15451040 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.73 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.25 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.51 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.51 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
7.69 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.69 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.00 | 16904648 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.41 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.17 | 17150277 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.23 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.78 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.76 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.34 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.34 | 15692506 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.59 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.96 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.96 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.46 | 16144979 16879835 16244371 14766674 16330681 16244372 17888722 16495754 12587719 17875725 18674790 18006777 16707910 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
7.46 | 16046796 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.04 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
7.04 | 16011733 12660669 16845234 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.65 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.02 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.09 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.25 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.34 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.34 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
7.53 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.53 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.75 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.28 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
11.12 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.12 | 18501091 15147373 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
11.12 | 18180244 17606976 16200630 16135485 15147373 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.47 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 8697196 18606429 16959395 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.50 | 18783367 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.25 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
4.82 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.37 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
4.72 | 16933029 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.63 | 16046005 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.59 | 15086907 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.95 | 17933447 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.67 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.80 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.81 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.01 | 16612254 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.37 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.59 | 16096441 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.36 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.13 | 15811171 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.05 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
6.53 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.53 | 17581917 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
7.45 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.45 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.45 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.83 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
6.83 | 14714311 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.73 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.29 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.29 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.35 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.35 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
9.35 | 11041285 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.90 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.11 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.11 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.11 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
9.26 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
9.26 | 15451040 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
13.89 | 15070760 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
13.89 | 19148494 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
13.89 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
13.89 | 18980019 19235587 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.87 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.38 | 17802794 17658394 17008537 18172266 18587576 17296974 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.55 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.03 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
7.94 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
7.94 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
14.68 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
14.68 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
14.68 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.95 | 20471514 16968895 16467208 19850784 17050201 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
5.95 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.95 | 17679729 18704418 19010910 18206229 18460780 19387464 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.18 | 18055864 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
4.93 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.03 | 16330433 16112521 17869043 17649720 17712046 19035177 16331271 19642359 9834237 16823087 12712474 17107899 15748426 11468182 12018890 16891316 15336539 19075265 17217047 16966277 12679006 11161223 15622746 15213294 19225113 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.09 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.69 | 10052129 11830472 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.62 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
7.42 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
7.42 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.20 | 16943688 17174718 11408273 17157831 16221502 11903743 16239168 17334410 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
10.20 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.20 | 21047994 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.82 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.02 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.25 | 17805973 18006644 18376398 16015684 17631135 14512876 12958196 16248980 16192424 18277467 18251166 14724832 17714472 16116963 18187930 16638106 18412020 20821823 15818738 18395914 15338365 14716496 18210741 11481614 17761835 18166357 17708605 15931870 17766677 15925388 12632512 17823541 13678700 17944888 16097048 15650968 18418968 12649538 18395095 18472094 12609069 15057751 18420326 12898905 16011737 17869086 17525996 15893842 17976157 17565644 12667390 18481824 15959796 18317297 18429990 17481882 12586293 17698563 18156304 15730626 10355542 18054572 14716833 16136751 18263696 17557913 15123356 14620537 17721639 17922224 18279442 12445418 16027843 18472332 18339082 15370692 18205269 14748882 15996030 12389079 15052691 12632514 16033810 18705752 12741479 12666154 12445421 15673190 17640975 12546737 15362042 17900296 15876570 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.25 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.25 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
8.25 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.25 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.25 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.85 | 16246199 16964402 15720792 17285989 15830285 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.85 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.38 | 17347304 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.89 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.45 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
24.05 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
24.05 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
24.05 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
24.05 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
24.05 | 8742319 15975961 19482888 19073162 21047994 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
24.05 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.05 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
24.05 | 16391232 17559639 17093202 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
25.61 | 3712494 598648 6587162 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
25.61 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
25.61 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
25.61 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
25.61 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
25.61 | 1399818 2563599 17172636 18308698 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
25.61 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
7.92 | 15213294 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
7.92 | 20210726 |
MESH:D008171 |
Lung Diseases |
|
2-chloroethyl ethyl sulfide |
4.44 | 16252256 18675330 12815614 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
14.68 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
14.68 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
14.68 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.68 | 18569708 20135361 18816296 6695378 20064080 17053015 20869020 18520028 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
14.68 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide |
14.68 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
14.68 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.68 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
14.68 | 16926031 15902970 10530776 11544531 17195641 12957351 16204055 16391232 17093202 12466968 12117781 16289808 15166089 6695378 11992545 11893704 15136453 10822126 11807781 11497255 17255336 11246140 12765245 7750092 11323394 16337739 11062179 10779650 10997738 14587096 16788158 11552296 11074608 11307925 16007126 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
16.33 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
16.33 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
16.33 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
16.33 | 12854902 12556972 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
9.53 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
9.53 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
8.24 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.24 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.29 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.48 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
8.96 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.96 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
8.96 | 16827153 14580682 19196722 11731420 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.70 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.70 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
4.86 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.86 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.86 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.90 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.53 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.92 | 15451040 18411066 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
7.67 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
7.67 | 16856516 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.95 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.14 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.18 | 19142101 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.25 | 15792986 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.80 | 19299654 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.98 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.51 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
11.11 | 19549372 14977855 11468182 19417148 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
11.11 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.11 | 18172295 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.39 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
11.54 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
11.54 | 17596541 17611569 19805378 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
11.54 | 16882708 19010910 19157545 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
5.99 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.99 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.80 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.07 | 16810080 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.20 | 17484760 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.69 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.85 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.85 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.85 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.42 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
10.81 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
10.81 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
10.81 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Urethane |
10.81 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
4.41 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.72 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.45 | 17289903 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.59 | 15086907 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.49 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.77 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.58 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.58 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.65 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
6.65 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.73 | 8761367 16115947 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.73 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.61 | 12837982 8761367 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.07 | 8291058 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
5.43 | 9802331 20557099 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.59 | 17945291 |
MESH:D009765 |
Obesity |
|
2-chloroethyl ethyl sulfide |
7.50 | 16289378 |
MESH:D009765 |
Obesity |
|
Clozapine |
7.50 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
olanzapine |
7.50 | 18515891 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.18 | 6482804 4026338 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.43 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.73 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.08 | 17016548 |
MESH:C536063 |
Osteoporosis-pseudoglioma syndrome |
|
pamidronate |
6.74 | 18825883 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.89 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
10.60 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
10.60 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.60 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
10.60 | 16391232 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.41 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
19.17 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
19.17 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
19.17 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
19.17 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
19.17 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
19.17 | 16965848 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.21 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.90 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.96 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.19 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.87 | 17983394 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
5.14 | 16391232 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.87 | 17638057 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.37 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.39 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.65 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.91 | 11399792 11896295 11222880 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.45 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.43 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
3.43 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.43 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.43 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.43 | 18437689 15897917 16888761 16868541 15749863 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.43 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
3.43 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide |
3.43 | 18798265 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.43 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.43 | 15067354 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.21 | 12752131 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
5.31 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
8.71 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
8.71 | 16134406 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.18 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.95 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
3.77 | 16526316 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
2-chloroethyl ethyl sulfide |
9.07 | 12210543 18257742 16292752 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
9.07 | 12394941 16096441 15912074 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.17 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.14 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.75 | 15675481 17203757 18313854 16767912 17710206 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
15.78 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
15.78 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
15.78 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.51 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
4.18 | 18855531 20521326 16141801 17726453 20107430 11763009 20580759 17123785 18806925 19369910 17667964 20452607 20521320 20168265 11151749 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
4.18 | 20107430 17726453 20521326 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.56 | 16636934 |
MESH:D012640 |
Seizures |
|
Cocaine |
9.01 | 10454489 |
MESH:D012640 |
Seizures |
|
Ethanol |
9.01 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
9.01 | 3137016 11442880 16876388 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.54 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.52 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
12.52 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.52 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
12.52 | 11807781 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.29 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.01 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.23 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.76 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
6.09 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
6.09 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
6.09 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
6.09 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
6.09 | 17052386 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.29 | 11906479 9562338 17918041 9211565 17189318 16755016 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.01 | 9754883 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.78 | 12837982 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
5.07 | 20210726 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
4.54 | 6499806 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
20.25 | 1399818 3712494 7505956 6582329 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
20.25 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
20.25 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
20.25 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
20.25 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.40 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.68 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
22.43 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
22.43 | 11780464 12845720 12973940 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
22.43 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
22.43 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
22.43 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
22.43 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
22.43 | 17572228 16712894 8653321 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.63 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.63 | 10620525 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.95 | 16364871 17638931 17334414 17678736 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
9.57 | 16141801 20107430 20564506 20521320 16402076 17502770 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
9.57 | 17933447 19434072 20107430 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.80 | 17933447 |